Free Webinar: Italfarmaco Givinostat Development Program Update
Please join us on Thursday, September 12, 2019, from 9:00 AM to 10:00 AM Pacific Time, to get updates on Italfarmaco’s Givinostat clinical trial, which is currently recruiting ambulatory boys who are on steroid therapy.
The webinar will review the Italfarmaco Givinostat development program for Duchenne and Becker Muscular Dystrophy. Content that will be covered, includes:
Updates from the EPIDYS Study, a phase 3 clinical trial of Givinostat in ambulatory boys with DMD.
Data from Italfarmaco’s long term studies of Givinostat in DMD populations.
30 minute Q & A.
Paolo Bettica, MD, PhD Vice President of Research and Development, Italfarmaco S.p.A
Michael Kelly, Chief Scientific Advisor, CureDuchenne
Ana Christensen, Patient Science Liaison, TRINDS